Terms: = Head and neck cancer AND BCL3, P20749, 602, ENSG00000069399, D19S37, BCL4 AND Staging
9 results:
1. Nomograms for predicting overall survival and cancer-specific survival in patients with head and neck non-Hodgkin lymphoma: A population-based study.
Peng J; Chen J; Liu Y; Lyu J; Zhang B
Medicine (Baltimore); 2023 Feb; 102(6):e32865. PubMed ID: 36820559
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of soft tissue deposits in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Kaul P; Malhotra M; Arora V; Agarwal N; Singh MP; Garg PK
Int J Oral Maxillofac Surg; 2023 Sep; 52(9):917-922. PubMed ID: 36781359
[TBL] [Abstract] [Full Text] [Related]
3. Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study.
Zhu X; Heng Y; Zhou L; Zhang M; Li W; Tao L
Int J Clin Oncol; 2020 Aug; 25(8):1483-1491. PubMed ID: 32462387
[TBL] [Abstract] [Full Text] [Related]
4. Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.
Caula A; Boukhris M; Guerlain J; Tao Y; Breuskin I; Mirghani H; Temam S; Gorphe P
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1161-1166. PubMed ID: 30666440
[TBL] [Abstract] [Full Text] [Related]
5. Evolution in the profile of thyroid cancer cases treated in an oncology reference service: what changed in the last 20 years.
Lira RB; Carvalho GB; Gonçalves Filho J; Kowalski LP
Rev Col Bras Cir; 2014; 41(5):320-4. PubMed ID: 25467095
[TBL] [Abstract] [Full Text] [Related]
6. The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma.
Francis AM; Sepesi B; Correa AM; Blum MA; Erasmus JJ; Lee JH; Maru DM; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Walsh GL; Welsh JW; Swisher SG; Hofstetter WL;
Ann Surg; 2013 Sep; 258(3):500-7. PubMed ID: 24022442
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.
Chen L; Liu LZ; Chen M; Li WF; Yin WJ; Lin AH; Sun Y; Li L; Ma J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):196-202. PubMed ID: 22300569
[TBL] [Abstract] [Full Text] [Related]
8. [Preliminary study on the value of 99Tc(m)-HL91 imaging in predicting sensitivity to radiotherapy in patients with nasopharyngeal carcinoma].
Liu S; Xue Y; Zhang H; Liang JG; Lu XP; Liu XG; Chen SX; Jing NY
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):369-72. PubMed ID: 17892134
[TBL] [Abstract] [Full Text] [Related]
9. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract] [Full Text] [Related]
